Established in 2013, OBiO Technology (Shanghai) Corp., Ltd.（Stock：688238）is a pioneering Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO) in cell and gene therapy, offering comprehensive solutions; provides a range of technical services for the field of Regenerative Medicine and Anti-aging (Life&Health CDMO) , include cell preparation, production of recombinant proteins/exosomes, and cell storage. Guided by our mission" Enable Cell and Gene Therapy for Better Lives", We are dedicated to delivering top-tier services globally. From bench to clinic, we are committed to advancing your product and benefiting populations worldwide.As OBiO Technology swiftly evolves, adheres to the philosophy of ""Integrating our resources to serve life sciences.""  Every OBiOers are immersed in "Customer Focus、Efficient Execution、 Excellence、Innovation、Integrity "，It has grown into a high-tech enterprise integrating three development directions of basic Contract Research Organization (CRO) ，Contract Development and Manufacturing Organization (CDMO) in cell and gene therapy, and Regenerative Medicine  (Life& Health CDMO) .